BioCentury
ARTICLE | Clinical News

Xarelto rivaroxaban regulatory update

April 27, 2009 7:00 AM UTC

The U.K.'s NICE issued final guidance recommending use of Xarelto rivaroxaban from Bayer to prevent venous thromboembolism (VTE) in adults having elective total hip or knee replacement surgery. The gu...